藥學前沿大講堂第258講

題目: The Cytochrome P450 Fatty Acid Metabolite 20-HETE and Brain Hypoperfusion: A Target for Drug Development? 

報告人: Samuel Mark Poloyac 教授，美國匹茲堡大學

主持人: 徐峻教授，太阳集团1088vip

時間: 2016年9月3日（周六）15:00-16:00

地點: 中山大學東校區行政樓B101

報告人簡介:

Samuel M. Poloyac, PharmD, PhD, FCCM is a Professor of Pharmaceutical Sciences and the Associate Dean for Graduate and Postdoctoral Programs at the University of Pittsburgh School of Pharmacy.  Dr. Poloyac also serves as the Director of the Center for Clinical Pharmaceutical Sciences and the Director of the Small Molecule Biomarker Core Laboratory at the University of Pittsburgh.  Dr. Poloyac graduated from the University of Pittsburgh with a BS in Pharmacy (1993), and then completed his PharmD (1995) and PhD (1999) degrees at the University of Kentucky. Upon returning to the University of Pittsburgh as a faculty member (1999), Dr. Poloyac has focused on determining the role of drug metabolizing, cytochrome P450, enzymes on fatty acid bioactivation and drug disposition in the pathogenesis of disease in critically ill patients.  Research in his laboratory utilizes relevant models of disease and translates these findings to critically ill patients.  The NIH and the American Heart Association have supported his research, leading to over 74 peer-reviewed publications. Dr. Poloyac has served as a reviewer for the National Institutes of Health and for numerous scientific journals.  Dr. Poloyac is a Fellow of the Society of Critical Care Medicine and is a 2015-16 Fellow of the AACP Academic Leadership Fellow Program.  Dr. Poloyac is committed to the advancement of pharmacy and pharmaceutical sciences both through research and through the training of the next generation of pharmacists and clinical pharmaceutical scientists.  

歡迎廣大師生踴躍參與！